Aarti Drugs Share Price

Aarti Drugs Limited is an India-based company, which is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates in the pharmaceuticals segment. Its geographical segments include Out of India and India. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals include benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.As of 25 May 2026, Aarti Drugs share price is ₹394.45. The stock opened at ₹393.00, compared to its previous close of ₹389.95. During today's trading session, Aarti Drugs share price moved in the range of ₹388.60 to ₹399.00, with an average price of ₹393.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹388.60 and a high of ₹399.00. On the performance front, Aarti Drugs share price has declined by 7.88% over the last six months and is down 16.82% on a year-on-year basis.

The market capitalization of Aarti Drugs is ₹3,555 Crs, with a P/E ratio of 18.2 and a dividend yield of 0.00%.